July 2020 Issue – Practical Dermatology
Practical Dermatology is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in medical and cosmetic dermatology.
Related Articles
Journal Club: Dupilumab and Atopic March
Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indic…
First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cells
The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced…
SEEN Expands Pediatric Line with Fragrance-Free Baby Shampoo and Body Wash
SEEN has announced the launch of SEEN Baby 2-in-1 Fragrance Free, a new ultra-gentle shampoo and body wash designed specifically for infants and young chi…
RILECSU Study: Rilzabrutinib Effective for Symptoms in Hard-to-Treat Urticaria
Rilzabrutinib significantly reduced itch and hives in adults with antihistamine-refractory chronic spontaneous urticaria (CSU), according to new phase 2 t…
Lebrikizumab Achieves Deep and Sustained Response at 3 Years in AD
Lebrikizumab (EBGLYSS) achieved deep and sustained response for patients with moderate-to-severe atopic dermatitis (eczema) at 3 years in the ADjoin long-…
A New Year and New Beginnings
The Practical Dermatology Podcast returns with the latest news to start 2025 and a conversation between Chief Medical Editor Neal Bhatia, MD, FAAD, and ne…
Practical Dermatology Names Dr. Lisa Swanson Associate Medical Editor
Elizabeth (Lisa) Swanson, MD, FAAD, has accepted the position of Associate Medical Editor of Practical Dermatology, the journal announced. In this capacit…
Vtama Approved for AD in Adults and Children
In this week’s DermwireTV, the FDA approves Vtama (tapinarof cream 0.1%) for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizu…
Study: Cutaneous Lupus Linked With Elevated Cardiovascular Disease Risk
Patients with cutaneous lupus erythematosus (CLE) face an elevated risk of atherosclerotic cardiovascular disease (ASCVD), comparable to that seen in syst…
FDA Greenlights BIMZELX for Chronic Hidradenitis Suppurativa
The Food and Drug Administration (FDA) has approved BIMZELX® (bimekizumab-bkzx) for adults with moderate-to-severe hidradenitis suppurativa (HS), making i…